Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Drug Resistance

Free Subscription 21.11.2019 2 Antimicrob Agents Chemother 4 Clin Infect Dis 1 Infect Control Hosp Epidemiol 1 Int J Antimicrob Agents 2 J Antimicrob Chemother 1 J Infect Dis 1 J Virol 4 Nat Med 1 PLoS Comput Biol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Antimicrob Agents Chemother

1. WATSON A, Sauve K, Cassino C, Schuch R, et al
   Exebacase demonstrates in vitro synergy with a broad range of antibiotics against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
   Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01885.
   PubMed     Text format     Abstract available
   
   
2. CASTANHEIRA M, Doyle TB, Kantro V, Mendes RE, et al
   Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals During 2016-2018.
   Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01951.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

3. ECHOLS R, Ariyasu M, Nagata TD
   Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance.
   Clin Infect Dis. 2019;69.
   PubMed     Text format     Abstract available
   
   
4. BONOMO RA
   Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens.
   Clin Infect Dis. 2019;69.
   PubMed     Text format     Abstract available
   
   
5. NORDMANN P, Poirel L
   Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.
   Clin Infect Dis. 2019;69.
   PubMed     Text format     Abstract available
   
   
6. DOI Y
   Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.
   Clin Infect Dis. 2019;69.
   PubMed     Text format     Abstract available
   
   

   
   Infect Control Hosp Epidemiol

7. LERNER AO, Abu-Hanna J, Carmeli Y, Schechner V, et al
   Environmental contamination by carbapenem-resistant Acinetobacter baumannii: The effects of room type and cleaning methods.
   Infect Control Hosp Epidemiol. 2019 Nov 14:1-6. doi: 10.1017/ice.2019.
   PubMed     Text format     Abstract available
   
   

   
   Int J Antimicrob Agents

8. AGYEMAN AA, Bergen PJ, Rao GG, Nation RL, et al
   A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections.
   Int J Antimicrob Agents. 2019 Oct 30. pii: S0924-8579(19)30294.
   PubMed     Text format     Abstract available
   
   

   
   J Antimicrob Chemother

9. ZHANG Y, Jin L, Ouyang P, Wang Q, et al
   Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
   J Antimicrob Chemother. 2019 Nov 12. pii: 5622907. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
10. SAVOLDI A, Carrara E, Gladstone BP, Azzini AM, et al
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    J Antimicrob Chemother. 2019;74:3619-3625.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

11. OLESEN SW, Torrone EA, Papp JR, Kirkcaldy RD, et al
    Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.
    J Infect Dis. 2019;219:619-623.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

12. YOSHIDA T, Shiraishi T, Hagiwara-Komoda Y, Komatsu K, et al
    The Plant Noncanonical Antiviral Resistance Protein JAX1 Inhibits Potexviral Replication by Targeting the Viral RNA-Dependent RNA Polymerase.
    J Virol. 2019;93.
    PubMed     Text format     Abstract available
    
    

    
    Nat Med

13. DIDELOT X, Pouwels KB
    Machine-learning-assisted selection of antibiotic prescription.
    Nat Med. 2019;25:1033-1034.
    PubMed     Text format    
    
    
14. DOAN T, Hinterwirth A, Worden L, Arzika AM, et al
    Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution.
    Nat Med. 2019;25:1370-1376.
    PubMed     Text format     Abstract available
    
    
15. YANT SR, Mulato A, Hansen D, Tse WC, et al
    A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.
    Nat Med. 2019;25:1377-1384.
    PubMed     Text format     Abstract available
    
    
16. BHUTTA ZA
    The benefits and risks of mass antibiotic use for reducing child mortality.
    Nat Med. 2019;25:1332-1334.
    PubMed     Text format    
    
    

    
    PLoS Comput Biol

17. DUVAL A, Obadia T, Boelle PY, Fleury E, et al
    Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings.
    PLoS Comput Biol. 2019;15:e1006496.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

18. GARCIA PK, Annamalai T, Wang W, Bell RS, et al
    Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.
    PLoS One. 2019;14:e0207733.
    PubMed     Text format     Abstract available
    
    
19. VICETTI MIGUEL CP, Mejias A, Leber A, Sanchez PJ, et al
    A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience.
    PLoS One. 2019;14:e0212029.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: